Cargando…

A Novel YTHDF3-Based Model to Predict Prognosis and Therapeutic Response in Breast Cancer

Background: Due to high tumor heterogeneity, breast cancer (BC) patients still suffer poor survival outcomes. YTHDF3 plays a critical role in the prognosis of BC patients. Hence, we aimed to construct a YTHDF3-based model for the prediction of the overall survival (OS) and the sensitivity of therape...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jie, Zhu, Jing, Wang, Xin, Zhou, Zhisheng, Liu, Haiyan, Zhu, Dajiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218665/ https://www.ncbi.nlm.nih.gov/pubmed/35755811 http://dx.doi.org/10.3389/fmolb.2022.874532

Ejemplares similares

Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
por: Bian, Saiyan, et al.
Publicado: (2020)

Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer
por: Zheng, Hang, et al.
Publicado: (2021)

A Metabolic Gene Signature to Predict Breast Cancer Prognosis
por: Lu, Jun, et al.
Publicado: (2022)

Identification of a Novel Protein-Based Signature to Improve Prognosis Prediction in Renal Clear Cell Carcinoma
por: Chu, Guangdi, et al.
Publicado: (2021)

Prediction of prognosis and immunotherapy response in breast cancer based on neutrophil extracellular traps-related classification
por: Zhao, Jiajing, et al.
Publicado: (2023)

Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
por: Tong, Wen, et al.
Publicado: (2022)

A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2022)

A Risk Prediction Model for Breast Cancer Based on Immune Genes Related to Early Growth Response Proteins Family
por: Zhou, Xin, et al.
Publicado: (2021)

Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer
por: Liu, Bangquan, et al.
Publicado: (2022)

Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma
por: Liu, Lixia, et al.
Publicado: (2021)

An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma
por: Zhang, Hongpan, et al.
Publicado: (2021)

A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer
por: Ye, Ying, et al.
Publicado: (2021)

Construction of m6A-based prognosis signature and prediction for immune and anti-angiogenic response
por: Wang, Xiang-Xu, et al.
Publicado: (2022)

Development of an Aging-Related Gene Signature for Predicting Prognosis, Immunotherapy, and Chemotherapy Benefits in Rectal Cancer
por: Wang, Yangyang, et al.
Publicado: (2022)

Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

A Metabolism-Related Radiomics Signature for Predicting the Prognosis of Colorectal Cancer
por: Cai, Du, et al.
Publicado: (2021)

Identification of a Novel Tumor Microenvironment–Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2020)

SMPDL3B Predicts Poor Prognosis and Contributes to Development of Acute Myeloid Leukemia
por: Qu, Huiqing, et al.
Publicado: (2021)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
por: Yang, Yuan, et al.
Publicado: (2021)

Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
por: Huang, Anmin, et al.
Publicado: (2022)

A Novel Gene Signature Associated With “E2F Target” Pathway for Predicting the Prognosis of Prostate Cancer
por: Xia, Haoran, et al.
Publicado: (2022)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

A novel necroptosis-related gene signature for predict prognosis of glioma based on single-cell and bulk RNA sequencing
por: Guo, Kai, et al.
Publicado: (2022)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2021)

Upregulation of circ_0008812 and circ_0001583 predicts poor prognosis and promotes breast cancer proliferation
por: Lin, Hong, et al.
Publicado: (2022)

Amino acid metabolism genes associated with immunotherapy responses and clinical prognosis of colorectal cancer
por: Peng, Xinyi, et al.
Publicado: (2022)

A Nomogram Model for Predicting the Response to Transcatheter Arterial Embolization in Patients With Symptomatic Hepatic Hemangioma
por: Liu, Qinqin, et al.
Publicado: (2021)

Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma
por: Wang, Wenjuan, et al.
Publicado: (2022)

Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications
por: Afzal, Samia, et al.
Publicado: (2022)

Novel Therapeutic Targets in Liver Fibrosis
por: Zhang, Jinhang, et al.
Publicado: (2021)

Comprehensive Analysis of Necroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients With Colon Cancer
por: Liu, Li, et al.
Publicado: (2022)

Decreased Expression of PACSIN1 in Brain Glioma Samples Predicts Poor Prognosis
por: Zimu, Zhou, et al.
Publicado: (2021)

Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma
por: Liu, Shixian, et al.
Publicado: (2022)

Identification and Development of a Novel 4-Gene Immune-Related Signature to Predict Osteosarcoma Prognosis
por: Cao, Mingde, et al.
Publicado: (2020)

A metabolism-associated gene signature for prognosis prediction of hepatocellular carcinoma
por: Tian, Yilin, et al.
Publicado: (2022)

Significance of Parkinson Family Genes in the Prognosis and Treatment Outcome Prediction for Lung Adenocarcinoma
por: Li, Yanqi, et al.
Publicado: (2021)

Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Fan, Ming, et al.
Publicado: (2021)

Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

CircRNAs as Novel Biomarkers and Therapeutic Targets in Renal Cell Carcinoma
por: Zhou, Yuxia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_19qh4tumiqfi0lqlongc24da39